No takes yet. Share an insight, caveat, or question.
Randomized trial identifies natural killer cell subsets via monoclonal antibodies, highlighting their specific markers.
Lohmeyer et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: